Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

¹M.D., Professor, Maltepe University Faculty of Medicine, Department of Ophthalmology, Istanbul/TURKEY
²M.D., Asistant Professor, Maltepe University Faculty of Medicine, Department of Ophthalmology, Istanbul/TURKEY Over the past few years, anti-VEGF therapy has become a gold standard treatment for neovascular age-related macular degeneration. Treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies. Keywords : Age-related macular degeneration, anti-VEGF therapy